Research Grants
Funding For:
The Effects of Physicians’ Financial Transfers from Drug Firms on Prescribing of Physician-Administered Cancer Drugs
Cost & Quality / Prescription Drugs
Recipient:
Colleen Carey, Cornell University
Grant Period:
Jan 01, 2023 - Dec 31, 2023
AMOUNT:
$53,758.00
Summary of the Project:
Physicians commonly receive marketing-related payments from drug firms. This research team will examine the impact of this practice on the prescribing of physician-administered cancer drugs in Medicare and the effect on cancer patients’ mortality rates. The study may inform ongoing policies at hospitals on drug firms’ physician-directed marketing guidelines, as well as changes to the prescribing and payment of cancer drugs in Medicare.
Grantee Publications
February 2025
Nothing for something: Marketing cancer drugs to physicians increases prescribing without improving mortality
Learn MoreAuthor: Colleen Carey, Michael Daly, Jing Li
December 2023
Biosimilars engage in low levels of direct-to-physician marketing relative to reference biologics
Learn MoreAuthor: Megan F Hyland, Colleen M Carey